Presentation is loading. Please wait.

Presentation is loading. Please wait.

Individual values for the tTg-IgA Celikey assay (A), the tTG-IgG Celikey assay (B), the DGP (IgA+IgG) screen (C), and the tTG-IgA Immulite 2000 assay (D),

Published byBritt-Marie Eriksson Modified over 5 years ago

Similar presentations

Presentation on theme: "Individual values for the tTg-IgA Celikey assay (A), the tTG-IgG Celikey assay (B), the DGP (IgA+IgG) screen (C), and the tTG-IgA Immulite 2000 assay (D),"— Presentation transcript:

1 Individual values for the tTg-IgA Celikey assay (A), the tTG-IgG Celikey assay (B), the DGP (IgA+IgG) screen (C), and the tTG-IgA Immulite 2000 assay (D), stratified according to the Marsh grading of biopsy findings. Individual values for the tTg-IgA Celikey assay (A), the tTG-IgG Celikey assay (B), the DGP (IgA+IgG) screen (C), and the tTG-IgA Immulite 2000 assay (D), stratified according to the Marsh grading of biopsy findings. Dashed lines represent assay cutoff values, and bars represent median Ab levels. Miriam Parizade et al. Clin. Vaccine Immunol. 2009; doi: /CVI

Download ppt "Individual values for the tTg-IgA Celikey assay (A), the tTG-IgG Celikey assay (B), the DGP (IgA+IgG) screen (C), and the tTG-IgA Immulite 2000 assay (D),"

Similar presentations

Tissue Transglutaminase IgA and IgG Correlation with Histology and their Role in a ‘Celiac Panel’; an Institutional Experience Shana Godfred-Cato, DO,

Tissue Transglutaminase IgA and IgG Correlation with Histology and their Role in a ‘Celiac Panel’; an Institutional Experience Shana Godfred-Cato, DO,
Centers for Disease Control/Food and Drug Administration algorithm for second-generation HIV tests (20). †, an immunofluorescence assay (IFA) for HIV-1.

Centers for Disease Control/Food and Drug Administration algorithm for second-generation HIV tests (20). †, an immunofluorescence assay (IFA) for HIV-1.
FMDV-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type O)

FMDV-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type O)
Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.

Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.
Protection from influenza virus challenge.

Protection from influenza virus challenge.
FMD VP1-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type.

FMD VP1-specific IgG, IgG1, and IgG2 in sera of guinea pigs (n = 6/group) immunized on days 1 and 21 by intramuscular injection of FMDV antigens (type.
Identification of novel IgGs in alpaca serum.

Identification of novel IgGs in alpaca serum.
Detection of CSFV-specific antibodies in immunized/challenged pigs using blocking ELISA. Groups of pigs (n = 5) were inoculated with different doses of.

Detection of CSFV-specific antibodies in immunized/challenged pigs using blocking ELISA. Groups of pigs (n = 5) were inoculated with different doses of.
Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.

Virus-specific serum antibody response of BALB/c mice to DNA prime followed by VRP boost. Virus-specific serum antibody response of BALB/c mice to DNA.
IL-18; IL-18BP; and free, biologically active IL-18 levels in nonsevere versus severe dengue cases. IL-18; IL-18BP; and free, biologically active IL-18.

IL-18; IL-18BP; and free, biologically active IL-18 levels in nonsevere versus severe dengue cases. IL-18; IL-18BP; and free, biologically active IL-18.
Immune response to vaccination with AVA in healthy human subjects (human immunogenicity study). Immune response to vaccination with AVA in healthy human.

Immune response to vaccination with AVA in healthy human subjects (human immunogenicity study). Immune response to vaccination with AVA in healthy human.
Survival of BALB/c mice after HK/Syd challenge.

Survival of BALB/c mice after HK/Syd challenge.
Relationship between prechallenge AVA-induced TNA levels and probability of animal survival following lethal challenge with B. anthracis spores in rabbit.

Relationship between prechallenge AVA-induced TNA levels and probability of animal survival following lethal challenge with B. anthracis spores in rabbit.
CCL19 levels are elevated in Lyme disease cases with PTLDS

CCL19 levels are elevated in Lyme disease cases with PTLDS
Serum neutralizing antibody response of BALB/c mice to DNA prime followed by VRP boost. Serum neutralizing antibody response of BALB/c mice to DNA prime.

Serum neutralizing antibody response of BALB/c mice to DNA prime followed by VRP boost. Serum neutralizing antibody response of BALB/c mice to DNA prime.
Tetramer staining performed to determine frequencies of epitope-specific T cells after clearance of HPV16 infection but prior to isolation of T-cell clones.

Tetramer staining performed to determine frequencies of epitope-specific T cells after clearance of HPV16 infection but prior to isolation of T-cell clones.
Comparison of relative activity of Adjuplex and other commonly used adjuvants. Comparison of relative activity of Adjuplex and other commonly used adjuvants.

Comparison of relative activity of Adjuplex and other commonly used adjuvants. Comparison of relative activity of Adjuplex and other commonly used adjuvants.
Antibody endpoint titers induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.5% to 2% (vol/vol) oil, as measured.

Antibody endpoint titers induced by PfCelTOS vaccines containing various adjuvant formulations with emulsion doses of 0.5% to 2% (vol/vol) oil, as measured.
Longevity of mucosal and systemic antibody responses induced by pulmonary vaccination. Longevity of mucosal and systemic antibody responses induced by.

Longevity of mucosal and systemic antibody responses induced by pulmonary vaccination. Longevity of mucosal and systemic antibody responses induced by.
Determination of IL-5+ and IL-6+ cells in the lamina propria of the small intestines of mice receiving L. casei administration. Determination of IL-5+

Determination of IL-5+ and IL-6+ cells in the lamina propria of the small intestines of mice receiving L. casei administration. Determination of IL-5+

Similar presentations

Ads by Google